DCES (Max-Delbrueck-Centrum)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameDCES (Max-Delbrueck-Centrum)
Drug Alias Namebrain tumor gene therapy (Max-Delbrueck-Centrum)liver tumor gene therapy (Max-Delbrueck-Centrum)DCES
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBrain NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMax Delbruck Centrum Fur Molekulare Medizin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGOT Entwicklungs GmbHMax Delbruck Centrum Fur Molekulare Medizin
Active IndicationsN/A
Inactive IndicationsBrain NeoplasmsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A